The in vitro motility activity of β-cardiac myosin depends on the nature of the β-myosin heavy chain gene mutation in hypertrophic cardiomyopathy
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Several mutations in the beta-myosin heavy chain gene cause hypertrophic cardiomyopathy. This study investigates (1) the in vitro velocities of translocation of fluorescently-labelled actin by beta-myosin purified from soleus muscle of 30 hypertrophic cardiomyopathy patients with seven distinct beta-myosin heavy chain gene mutations: Thr124Ile, Tyr162Cys, Gly256Glu, Arg403Gln, Val606Met, Arg870His, and Leu908Val mutations; and (2) motility activity of beta-myosin purified from cardiac and soleus muscle biopsies in the same patients. The velocity of translocation of actin by beta-myosin purified from soleus or cardiac muscle of 22 normal controls was 0.48 +/- 0.09 micron s-1. By comparison, the motility activity was reduced in all 30 patients with beta-myosin heavy chain gene mutations (range, 0.112 +/- 0.041 to 0.292 +/- 0.066 micron s-1. Notably, the Tyr162Cys and Arg403Gln mutations demonstrated significantly lower actin sliding velocities: 0.123 +/- 0.044, and 0.112 +/- 0.041 micron s-1, respectively. beta-myosin purified from soleus muscle from four patients with the Arg403Gln mutation had a similar actomyosin motility activity compared to beta-myosin purified from their cardiac biopsies (0.127 +/- 0.045 micron s-1 versus 0.119 +/- 0.068 micron s-1, respectively). Since these seven mutations lie in several distinct functional domains, it is likely that the mechanisms of their inhibitions of motility are different.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Such an increased energetic cost of contraction with the Arg403Gln mutation in the intact mouse heart3 is thought to be consistent with several molecular studies suggesting a decrease in actomyosin motility20,21 that effectively puts an energetic “drag” on the wild-type myosin during shortening3,19,22.”
From iRhythm ZIO: The Diagnostic Yield of a 14-day Continuous Ambulatory ECG Monitor (Turakhia et al., diagnostic yield of extended ambulatory ECG monitoring) (2013) · cites this paper as [20]
Citations
Cites
MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures
Kraulis, P. J. (1991) · Journal of Applied Crystallography · doi:10.1107/s0021889891004399 · Cited by 14,085
Three-dimensional structure of myosin subfragment-1: a molecular motor
Rayment, I., Rypniewski, W., Schmidt-Base, K., Smith, R., Tomchick, D., Benning, M., Winkelmann, D., Wesenberg, G., & Holden, H. (1993) · Science · doi:10.1126/science.8316857 · Cited by 2,070 · cited 8×
“5)(Rayment et al., 1993b, 1995).”
BackgroundInfluentialStructure of the actin-myosin complex and its implications for muscle contraction
Rayment, I., Holden, H., Whittaker, M., Yohn, C., Lorenz, M., Holmes, K., & Milligan, R. (1993) · Science · doi:10.1126/science.8316858 · Cited by 1,813 · cited 8×
“5)(Rayment et al., 1993b, 1995).”
BackgroundInfluentialGeisterfer-Lowrance, A. A. T., Kass, S., Tanigawa, G., Vosberg, H.-P., McKenna, W., Seidman, C. E., & Seidman, J. G. (1990) · Cell · doi:10.1016/0092-8674(90)90274-i · Cited by 1,380 · cited 1×
“In some kindreds, HCM is caused by distinct mutations of the cardiac -myosin heavy chain ( - MHC) gene located on chromosome 14q1 (Geisterfer-Lowrance et al., 1990; Epstein et al., 1992b).”
BackgroundMutations in the Genes for Cardiac Troponin T and α-Tropomyosin in Hypertrophic Cardiomyopathy
Watkins, H., McKenna, W. J., Thierfelder, L., Suk, H. J., Anan, R., O'Donoghue, A., Spirito, P., Matsumori, A., Moravec, C. S., Seidman, J. G., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199504203321603 · Cited by 937 · cited 1×
“Among these are cardiac troponin-T (Watkins et al., 1995b), a-tropomyosin (Watkins et al., 1995b), myosin binding protein C (Bonne et al., 1995; Watkins et al., 1995a), the regulatory light chain (Poetter et al., 1996) and the essential light chain (Poetter et al., 1996).”
BackgroundWatkins, H., Rosenzweig, A., Hwang, D.-S., Levi, T., McKenna, W., Seidman, C. E., & Seidman, J. G. (1992) · New England Journal of Medicine · doi:10.1056/nejm199204233261703 · Cited by 747 · cited 1×
“One hypothesis suggests that missense mutations not associated with a charge change compared to -MHC gene will be benign whereas those that result in a charge change will be malignant (Watkins et al., 1992; Anan et al., 1994).”
BackgroundForce measurements by micromanipulation of a single actin filament by glass needles
Kishino, A., & Yanagida, T. (1988) · Nature · doi:10.1038/334074a0 · Cited by 679 · cited 1×
“This is supported by the data which demonstrate that the isolated head of myosin (S-1) can translocate actin filaments and generate force in vitro (Toyoshima et al., 1987; Kishino & Yanagida, 1988).”
BackgroundPredicting coiled coils by use of pairwise residue correlations.
Berger, B., Wilson, D. B., Wolf, E., Tonchev, T., Milla, M., & Kim, P. S. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.18.8259 · Cited by 622 · cited 1×
“However, analysis of the mutant amino acid sequences with the PAIRCOIL program (Berger et al., 1995), which predicts probability of forming coiled-coil sequence, shows no expected difference in the probability of coiled-coil structure with either of these two S-2 mutants.”
BackgroundFisher, A. J., Smith, C. A., Thoden, J., Smith, R., Sutoh, K., Holden, H. M., & Rayment, I. (1995) · Biochemistry · doi:10.1021/bi00028a004 · Cited by 600 · cited 3×
“BeF3 crystal structure (Fisher et al., 1995).”
BackgroundWatkins, H., Conner, D., Thierfelder, L., Jarcho, J. A., MacRae, C., McKenna, W. J., Maron, B. J., Seidman, J. G., & Seidman, C. E. (1995) · Nature Genetics · doi:10.1038/ng1295-434 · Cited by 590 · cited 1×
“Among these are cardiac troponin-T (Watkins et al., 1995b), a-tropomyosin (Watkins et al., 1995b), myosin binding protein C (Bonne et al., 1995; Watkins et al., 1995a), the regulatory light chain (Poetter et al., 1996) and the essential light chain (Poetter et al., 1996).”
Background
Research works printed but not linked: 1
- FANANAPAZIR, L., MCAREAVEY, D. & EPSTEIN, N. D. (1994) Hypertrophic cardiomyopathy. In Electrophysiology, From Cell to Bedside (edited by ZIPES, D. & JALIFE, J. ) pp. 769–79. Philadelphia: W. B. Saunders Co.
Cited by
The Genetic Basis for Cardiomyopathy
Seidman, J. G., & Seidman, C. (2001) · Cell · doi:10.1016/s0092-8674(01)00242-2 · Cited by 1,046
Structural Mechanism of Muscle Contraction
Geeves, M. A., & Holmes, K. C. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.687 · Cited by 781
Striated Muscle Cytoarchitecture: An Intricate Web of Form and Function
Clark, K. A., McElhinny, A. S., Beckerle, M. C., & Gregorio, C. C. (2002) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.18.012502.105840 · Cited by 674
“Many of these mutant myosins exhibit impaired ATPase activities, and the degree of impairment correlates with the severity of the disease (Cuda et al. 1997, Roopnarine & Leinwand 1998).”
BackgroundMyosin heavy chain isoform expression in the failing and nonfailing human heart
Miyata, S., Minobe, W., Bristow, M. R., & Leinwand, L. A. (2000) · Circulation Research · doi:10.1161/01.res.86.4.386 · Cited by 538
The Molecular Genetic Basis for Hypertrophic Cardiomyopathy
Marian, A. J., & Roberts, R. (2001) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2001.1340 · Cited by 438
Metadata
- Authors
- CUDA, G., FANANAPAZIR, L., EPSTEIN, N. D., & SELLERS, J. R.
- Affiliations
- National Institutes of Health (US)
- Venue
- Journal of Muscle Research & Cell Motility
- Published
- 1997-05
- Volume
- 18
- Issue
- 3
- Pages
- 275-283
- ISSN
- 0142-4319 (ISSN-L)
- 1573-2657
- OpenAlex
- W383489959
- Cited by
- 137
- References
- 39
- Citations by year
- 2025: 1 · 2024: 2 · 2023: 1 · 2022: 3 · 2021: 6 · 2020: 2 · 2019: 6 · 2018: 2 · 2017: 5 · 2016: 2 · 2015: 3 · 2014: 2 · 2013: 6 · 2012: 2
- FWCI
- 7.04
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Journal of Muscle Research and Cell Motility (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Keywords
- hypertrophic cardiomyopathy, beta-myosin heavy chain, myosin mutations, actomyosin motility, soleus muscle, myocardium, cardiac contractility
- MeSH terms
- Actins, Cardiomyopathy, Hypertrophic, Humans, Models, Biological, Myocardium, Myosins, Muscle, Skeletal, Myosin Heavy Chains
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The in vitro motility activity of β-cardiac myosin depends on the nature of the β-myosin heavy chain gene mutation in hypertrophic cardiomyopathy. https://app.cochat.ai/papers/10.1023/a:1018613907574
- The paper
- CUDA, G., FANANAPAZIR, L., EPSTEIN, N. D., & SELLERS, J. R. (1997). The in vitro motility activity of β-cardiac myosin depends on the nature of the β-myosin heavy chain gene mutation in hypertrophic cardiomyopathy. Journal of Muscle Research & Cell Motility. https://doi.org/10.1023/a%3A1018613907574
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.